Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-03-02

Clinical Trial Update: Liposomal Bupivacaine Versus Bupivacaine for for Postoperative Pain Control in Shoulder Surgery [Phase 4]

View source ↗

Summary

Phase 4 trial comparing liposomal bupivacaine to standard bupivacaine for postoperative pain control in shoulder surgery has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Liposomal bupivacaine (bupivacaine liposome injectable suspension)

Snippet

Sponsor: Bassett Healthcare | Conditions: Anesthesia, Local | Phase 4 | Status: COMPLETED